ORIC Has Appointed Jacob Chacko, MD as Chief Executive Officer
Rich Heyman, PhD will transition from interim CEO to Chairman of the ORIC Board of Directors
SAN FRANCISCO, May 7, 2018 -- (Healthcare Sales & Marketing Network) -- ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and develo... Biopharmaceuticals, Oncology, Personnel ORIC Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news